Tonix Pharmaceuticals (TNXP) Competitors $18.04 +0.03 (+0.17%) Closing price 04:00 PM EasternExtended Trading$17.94 -0.09 (-0.53%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNXP vs. TRML, ETON, RAPP, PRTC, MREO, ZVRA, ALT, ERAS, SANA, and SNDLShould you be buying Tonix Pharmaceuticals stock or one of its competitors? The main competitors of Tonix Pharmaceuticals include Tourmaline Bio (TRML), Eton Pharmaceuticals (ETON), Rapport Therapeutics (RAPP), PureTech Health (PRTC), Mereo BioPharma Group (MREO), Zevra Therapeutics (ZVRA), Altimmune (ALT), Erasca (ERAS), Sana Biotechnology (SANA), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry. Tonix Pharmaceuticals vs. Tourmaline Bio Eton Pharmaceuticals Rapport Therapeutics PureTech Health Mereo BioPharma Group Zevra Therapeutics Altimmune Erasca Sana Biotechnology SNDL Tonix Pharmaceuticals (NASDAQ:TNXP) and Tourmaline Bio (NASDAQ:TRML) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership. Does the media favor TNXP or TRML? In the previous week, Tourmaline Bio had 8 more articles in the media than Tonix Pharmaceuticals. MarketBeat recorded 12 mentions for Tourmaline Bio and 4 mentions for Tonix Pharmaceuticals. Tourmaline Bio's average media sentiment score of 1.12 beat Tonix Pharmaceuticals' score of 0.13 indicating that Tourmaline Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tonix Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tourmaline Bio 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, TNXP or TRML? Tourmaline Bio has lower revenue, but higher earnings than Tonix Pharmaceuticals. Tourmaline Bio is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTonix Pharmaceuticals$10.09M11.84-$116.66M-$2.54 thousand-0.01Tourmaline BioN/AN/A-$42.12M-$2.87-5.83 Does the MarketBeat Community believe in TNXP or TRML? Tonix Pharmaceuticals received 319 more outperform votes than Tourmaline Bio when rated by MarketBeat users. However, 100.00% of users gave Tourmaline Bio an outperform vote while only 60.78% of users gave Tonix Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTonix PharmaceuticalsOutperform Votes34160.78% Underperform Votes22039.22% Tourmaline BioOutperform Votes22100.00% Underperform VotesNo Votes Do institutionals & insiders believe in TNXP or TRML? 82.3% of Tonix Pharmaceuticals shares are owned by institutional investors. Comparatively, 91.9% of Tourmaline Bio shares are owned by institutional investors. 0.0% of Tonix Pharmaceuticals shares are owned by company insiders. Comparatively, 11.0% of Tourmaline Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, TNXP or TRML? Tonix Pharmaceuticals has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, Tourmaline Bio has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Do analysts rate TNXP or TRML? Tonix Pharmaceuticals currently has a consensus target price of $585.00, suggesting a potential upside of 3,051.09%. Tourmaline Bio has a consensus target price of $49.33, suggesting a potential upside of 195.06%. Given Tonix Pharmaceuticals' higher probable upside, analysts plainly believe Tonix Pharmaceuticals is more favorable than Tourmaline Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tonix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Tourmaline Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TNXP or TRML more profitable? Tourmaline Bio has a net margin of 0.00% compared to Tonix Pharmaceuticals' net margin of -1,197.86%. Tourmaline Bio's return on equity of -20.97% beat Tonix Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Tonix Pharmaceuticals-1,197.86% -163.95% -118.88% Tourmaline Bio N/A -20.97%-20.56% SummaryTourmaline Bio beats Tonix Pharmaceuticals on 12 of the 16 factors compared between the two stocks. Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNXP vs. The Competition Export to ExcelMetricTonix PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.09M$6.71B$5.49B$7.95BDividend YieldN/A3.05%5.11%4.22%P/E Ratio0.007.3522.6218.58Price / Sales11.50241.98397.85103.49Price / CashN/A65.8538.1834.62Price / Book0.006.496.744.25Net Income-$116.66M$143.41M$3.22B$248.18M7 Day Performance4.94%2.24%1.59%1.36%1 Month Performance3.38%7.16%4.09%3.85%1 Year Performance-96.81%-2.45%15.98%5.37% Tonix Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNXPTonix Pharmaceuticals2.2433 of 5 stars$18.04+0.2%$585.00+3,142.8%-96.9%$116.09M$10.09M0.0050Short Interest ↑TRMLTourmaline Bio2.6993 of 5 stars$16.68-1.3%$49.33+195.8%+8.7%$427.78MN/A-5.9144Analyst RevisionPositive NewsETONEton Pharmaceuticals2.545 of 5 stars$15.93+0.7%$27.67+73.7%+381.4%$426.27M$39.01M-72.2520Upcoming EarningsAnalyst RevisionNews CoverageRAPPRapport Therapeutics2.423 of 5 stars$11.48+8.1%$32.67+184.6%N/A$419.89MN/A-0.83N/APRTCPureTech Health2.1899 of 5 stars$17.33+1.1%$45.00+159.7%-38.1%$416.25M$3.33M0.00100News CoverageMREOMereo BioPharma Group2.3387 of 5 stars$2.60+3.8%$7.71+197.3%-15.1%$412.61M$1M-43.2540Positive NewsZVRAZevra Therapeutics2.7641 of 5 stars$7.20flat$22.29+209.5%+60.0%$393.69M$23.61M-3.6520Upcoming EarningsNews CoveragePositive NewsALTAltimmune2.5943 of 5 stars$5.02-1.1%$20.83+315.4%-19.8%$386.23M$20,000.00-3.2450Upcoming EarningsNews CoverageERASErasca2.9745 of 5 stars$1.36-2.5%$4.83+256.7%-27.4%$383.83MN/A-1.63120Analyst ForecastPositive NewsSANASana Biotechnology1.9107 of 5 stars$1.71-3.7%$10.80+533.4%-78.9%$383.67MN/A-1.22380Upcoming EarningsSNDLSNDL3.0502 of 5 stars$1.46-2.3%$3.63+149.1%-39.7%$382.34M$920.45M-4.69580Gap Down Related Companies and Tools Related Companies Tourmaline Bio Alternatives Eton Pharmaceuticals Alternatives Rapport Therapeutics Alternatives PureTech Health Alternatives Mereo BioPharma Group Alternatives Zevra Therapeutics Alternatives Altimmune Alternatives Erasca Alternatives Sana Biotechnology Alternatives SNDL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNXP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNXP Stock Free TNXP Stock Alerts